Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
492
datasets available to search
ShareScore release 0.9.0
Dataset results
492 results for “EGFR mutations;”
A Study of SKB264 in Combination With Osimertinib Versus Osimertinib in Patients With Epidermal Growth Factor Receptor (EGFR) Mutations, Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung
ClinicalTrials.gov study NCT06670196. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Icotinib as an Adjuvant Therapy for Patients With Stage IIA-IIIA Adenocarcinoma With EGFR Mutation
ClinicalTrials.gov study NCT02044328. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy of EGFR TKIs in Patients With Rare EGFR-mutated NSCLC
ClinicalTrials.gov study NCT01775943. IPD Sharing: Not stated. Countries: 1. Publications: 0.
First-in-Human Phase I/II Study of FHND-9041 in Patients With EGFR Mutated Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT06521034. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase II Study of Sacituzumab Tirumotecan in Combination With Osimertinib or Sacituzumab Tirumotecan for Neoadjuvant Treatment in Patients With Resectable Epidermal Growth Factor Receptor (EGFR)-Mutat
ClinicalTrials.gov study NCT07329322. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Icotinib as the Adjunctive Treatment After Surgery in Stage I-IIIB Lung Adenocarcinoma Patients With EGFR Gene Mutation
ClinicalTrials.gov study NCT02283424. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Other Oncogene Mutations for Anti-EGFR Efficacy in Patients With Left-sided RAS-wild Type Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT06226857. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study of Chemotherapy Plus Icotinib to Treat EGFR Mutation-positive Non-small-cell Lung Cancer
ClinicalTrials.gov study NCT02272127. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Icotinib Following Chemotherapy Versus Chemotherapy as Adjuvant Therapy in Stage IIA-IIIA NSCLC With EGFR Mutation
ClinicalTrials.gov study NCT01996098. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Metformin Plus Tyrosine Kinase Inhibitors for Treatment of Patients With Non-small Cell Lung Cancer With EGFR Mutations
ClinicalTrials.gov study NCT05445791. IPD Sharing: NO. Countries: 1. Publications: 0.
Preoperative Amivantamab or Amivantamab and Carboplatin/Pemetrexed Treatment in Patients With Resectable Non-small-cell Lung Cancer Harboring Oncogenic EGFR Mutations (NEOpredict-EGFR)
ClinicalTrials.gov study NCT06784791. IPD Sharing: NO. Countries: 3. Publications: 0.
Andamertinib as First-line Treatment for NSCLC With EGFR PACC or EGFR L861Q Mutation
ClinicalTrials.gov study NCT07336732. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Phase I/IIa Study of H002 in NSCLC With Active EGFR Mutation
ClinicalTrials.gov study NCT05519293. IPD Sharing: NO. Countries: 1. Publications: 0.
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
ClinicalTrials.gov study NCT06538038. IPD Sharing: NO. Countries: 1. Publications: 0.
The Detection of EGFR Mutations in Liquid Based Cytology Samples
ClinicalTrials.gov study NCT04086680. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Investigation of REcurrence Mechanisms to Adjuvant osimertINib in Radically Resected EGFR-mutated NSCLC Patients
ClinicalTrials.gov study NCT07363252. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Practical Usability of EGFR Mutation Detection in ctDNA From Resectable NSCLC
ClinicalTrials.gov study NCT04922073. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy Study of Osimertinib in Treatment-naïve Patients With EGFR Mutant NSCLC According to TP53 Mutational Status.
ClinicalTrials.gov study NCT05785208. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy and Safety of Platinum-based Chemotherapy + Bevacizumab + Durvalumab, and Salvage SBRT for IV Non-Small Cell Lung Cancer Patients With EGFR Mutations After Failure of First Line Osimertinib:
ClinicalTrials.gov study NCT04517526. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Osimertinib, Surgery, and Radiation Therapy in Treating Patients With Stage IIIB or IV Non-small Cell Lung Cancer With EGFR Mutations, NORTHSTAR Study
ClinicalTrials.gov study NCT03410043. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.